0001209191-21-050055.txt : 20210805 0001209191-21-050055.hdr.sgml : 20210805 20210805193409 ACCESSION NUMBER: 0001209191-21-050055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20210805 DATE AS OF CHANGE: 20210805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fisher Stewart CENTRAL INDEX KEY: 0001824863 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 211150151 MAIL ADDRESS: STREET 1: C4 THERAPEUTICS, INC. STREET 2: 490 ARSENAL WAY, SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-03 0 0001662579 C4 Therapeutics, Inc. CCCC 0001824863 Fisher Stewart C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #200 WATERTOWN MA 02472 0 1 0 0 Chief Scientific Officer Common Stock 2021-08-03 4 S 0 17057 45.0145 D 22744 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Shoaib Ghias, Attorney-in-Fact 2021-08-05